论文部分内容阅读
对于肝外恶性病变的患者,查出肝转移灶对予后和治疗具有极大重要性。肝扫描曾被夸为是侦查肝转移的一项安全和无害的方法,但尽管对肝扫描已积累大量经验,此法的确切作用仍不清楚。本文作者将临床估计和肝扫描结果作了比较,以确定肝扫描对判断肝内有无转移癌的价值。作者对111例病人进行了分析,111例系根据下列标准选入者:(1)有原发的肝外癌肿或淋巴肿瘤,(2)肝脏经组织学检查或剖腹探查已确定有无肝转移灶。病人分为两组,即证实有转移灶者39例和无转移灶者72例。临床上判断有无肝转移主要是根据体检肝是否增大及肝功能测定是否正常。肝功能化验主要用三个指标,碱性磷酸酶、SGOT、以及亮氨酸氨肽酶。其中两项测
For patients with extrahepatic malignancies, detecting liver metastases is of great importance for post-treatment and treatment. Liver scans have been hailed as a safe and harmless method of detecting liver metastases, but although the experience of liver scanning has accumulated a lot, the exact role of this method is still unclear. The authors compared clinical estimates with liver scans to determine the value of liver scans in judging whether there is metastatic cancer in the liver. The authors analyzed 111 patients and 111 patients were selected according to the following criteria: (1) primary extrahepatic cancer or lymphoma, (2) liver histological examination or laparotomy Metastasis. The patients were divided into two groups, ie, 39 cases with metastases and 72 cases without metastases. The clinical judgment of liver metastases is mainly based on whether the liver is enlarged and liver function tests are normal. Liver function tests mainly use three indicators, alkaline phosphatase, SGOT, and leucine aminopeptidase. Two of these tests